Hrt Financial LP Athersys, Inc Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.18 - $0.86 $2,941 - $14,052	16,340 Added 39.14%	58,084 $15,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $70,742 - $124,978	-117,904 Reduced 73.85%	41,744 $25,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $135,700 - $223,507	159,648 New	159,648 $144,000
Q3 2021 Nov 15, 2021	SELL	$1.33 - $1.77 $83,880 - $111,630	-63,068 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $88,925 - $122,351	63,068 New	63,068 $90,000
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $148,960 - $256,285	-92,522 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $143,409 - $207,249	92,522 New	92,522 $161,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.